MedPath

DEFEROXAMINE MESYLATE FOR INJECTION

DEFEROXAMINE MESYLATE FOR INJECTION

Discontinued
DIN Number

02261820

Drug Class

Human

Market Date

N/A

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02261820
AIG Number0109208001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AC01 DEFEROXAMINE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous ,  Subcutaneous ,  Intraperitoneal ,  Intramuscular
AHFS Classification64:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DEFEROXAMINE MESYLATEActive
Strength: 2 G / VIAL
Monograph: DEFEROXAMINE MESYLATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.